DigestRedComo funciona
Red
/
Empresas
Ki
No verificado

Kinaset Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa
20/07/2026
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Sanidad
Kinaset Therapeutics Announces First Patient Dosed in Phase 2b PANAIRAMA Trial of frevecitinib (KN-002) in Patients with Severe Asthma
Fuente
Kinaset Therapeutics, Inc.
Editor
Business Wire
1.00
0
30/06/2026
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Mercado laboral
Kinaset Therapeutics Appoints Daniel G. Welch as Board Chair and David Lubner as Independent Director and Audit Committee Chair
Fuente
Kinaset Therapeutics, Inc.
Editor
Business Wire
1.00
0
10/01/2026
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
Kinaset Therapeutics Announces $103 Million Oversubscribed Series B Financing to Advance Novel, Inhaled Therapeutic Candidate for Respiratory Diseases
Fuente
Kinaset Therapeutics, Inc.
Editor
Business Wire
1.00
0
29/01/2025
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Industria
Kinaset Therapeutics Announces FDA Clearance of IND Application for frevecitinib (KN-002) in Asthma Treatment
Fuente
Kinaset Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0